Interdict

Interdict develops small molecule therapeutics targeting undruggable oncology targets. In practice that means building software for you when nothing off the shelf fits.

Who is it for? Mostly companies with a specific process to automate. They also list Oncology and Therapeutics, so expect those to show up in the feature set. They are a small team, 11 to 50 people, which usually shapes who they work with. Small vendors mean quick answers and real influence on the roadmap, but check who covers support when someone is out.

Interdict is based in South San Francisco, California. Their site is interdictbio.com.

Before you commit, look at portfolio relevance, who owns the code, and how they handle changes. Get the renewal terms in writing before the first invoice.

Nobody has reviewed Interdict on Revaw yet. If you use it, your rating goes first, and it takes about twenty seconds.